Influence of Acetylcholine Esterase Inhibitors and Memantine, Clinically Approved for Alzheimer’s Dementia Treatment, on Intestinal Properties of the Mouse

An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer’s disease

(2020) Andrea Haake et al.   Expert Opinion On Drug Safety

Amyloidogenic Peptides in Human Neuro-Degenerative Diseases and in Microorganisms: A Sorrow Shared Is a Sorrow Halved?

(2020) Kristina Endres   MOLECULES

Memantine Displays Antimicrobial Activity by Enhancing Escherichia coli Pathogen-Induced Formation of Neutrophil Extracellular Traps

(2020) Liang Peng et al.   Frontiers in Cellular and Infection Microbiology

Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia

(2020) Howard A. Fink et al.   ANNALS OF INTERNAL MEDICINE

Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease

(2020) Mihai S. Cirstea et al.   MOVEMENT DISORDERS

A Perspective on Multi-target Drugs for Alzheimer’s Disease

(2020) Ondrej Benek et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Impact of Acute and Chronic Amyloid-β Peptide Exposure on Gut Microbial Commensals in the Mouse

(2020) Malena dos Santos Guilherme et al.   Frontiers in Microbiology

Alzheimer's disease in the gut—Major changes in the gut of 5xFAD model mice with ApoA1 as potential key player

(2020) Nicolai M. Stoye et al.   FASEB JOURNAL

Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs

(2020) Prabesh Kanel et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease

(2019) Sebastiaan P. van Kessel et al.   Nature Communications

Retinoic acid and the gut microbiota in Alzheimer’s disease: fighting back-to-back?

(2019) Kristina Endres   Current Alzheimer Research

Improvement of Language in Children with Autism with Combined Donepezil and Choline Treatment

(2019) Lidia V. Gabis et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Identification of Patulin from Penicillium coprobium as a Toxin for Enteric Neurons

(2019) Brand et al.   MOLECULES

Neuroimmune Interactions in the Gut and Their Significance for Intestinal Immunity

(2019) David J. Brinkman et al.   Cells

Prescribed Drugs and the Microbiome

(2019) Nele Brusselaers   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers

(2019) Kim San Tang   LIFE SCIENCES

Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease

(2019) Fadi S. Hanna Al-Shaikh et al.   JAMA Neurology

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease

(2019) Dongming Yang et al.   Frontiers in Neurology

The cholinergic activation of enteric glia is a physiological mechanism that contributes to the regulation of gastrointestinal motility

(2018) Ninotchska M Delvalle et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia

(2018) Ruth Knight et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer’s disease

(2018) Yazan S. Batarseh et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

The cholinergic anti-inflammatory pathway revisited

(2018) K. Murray et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Gastrointestinal Dysfunction in Parkinson’s Disease

(2018) Ronald F. Pfeiffer   Current Treatment Options in Neurology

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation

(2017) Dana Mohammad et al.   Expert Opinion On Drug Safety

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

(2017) Lídia Blanco-Silvente et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model

(2017) Carolin Brandscheid et al.   JOURNAL OF ALZHEIMERS DISEASE

Analysis of spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs

(2017) Kelvin K. L. Wong et al.   Organogenesis

Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer’s Disease

(2016) Virginia Boccardi et al.   JOURNAL OF ALZHEIMERS DISEASE

The intestinal cholinergic anti-inflammatory pathway

(2016) Gera Goverse et al.   JOURNAL OF PHYSIOLOGY-LONDON

Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy

(2016) Martin Valis et al.   NEUROTOXICITY RESEARCH

Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses

(2016) Oriana Rossi et al.   Scientific Reports

How informative is the mouse for human gut microbiota research?

(2015) T. L. A. Nguyen et al.   Disease Models & Mechanisms

Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates

(2015) Doris Vandeputte et al.   GUT

Genetically engineered mouse models for studying inflammatory bowel disease

(2015) Atsushi Mizoguchi et al.   JOURNAL OF PATHOLOGY

Procognitive Compounds Promote Neurite Outgrowth

(2015) Matthew Page et al.   PHARMACOLOGY

Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E. coli–Induced Pathogenicities through Disease-Associated Alpha7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory Responses

(2015) Jing-Yi Yu et al.   PLoS One

Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut

(2013) S. E. Winter et al.   SCIENCE

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

(2011) Martin Farlow et al.   BMC Neurology

Autonomic control of gut motility: A comparative view

(2010) Catharina Olsson et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: Possible pharmacological strategies

(2010) Tomohiro Nakamura et al.   CELL CALCIUM

The influence of donepezil and EGb 761 on the innate immunity of human leukocytes

(2010) Marta Sochocka et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Gastrointestinal Motility Monitor (GIMM)

(2010) Jill M. Hoffman et al.   Jove-Journal of Visualized Experiments

Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review

(2009) A. Kurz et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Cholinergic neurotransmission and muscarinic receptors in the enteric nervous system

(2009) Andrea M. Harrington et al.   PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY

Memantine Potentiates Agonist-Induced Ca2+ Responses in HEK 293 Cells

(2008) Alexandre Blanchard et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Pharmacodynamics of Memantine: An Update

(2008) C. Parsons et al.   Current Neuropharmacology

How long can patients with mild or moderate Alzheimer’s dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study

(2008) Y. Sun et al.   EUROPEAN JOURNAL OF NEUROLOGY

Expression of nicotinic acetylcholine receptors and subunit messenger RNAs in the enteric nervous system of the neonatal rat

(2008) A. Garza et al.   NEUROSCIENCE